In many eukaryotic signalling cascades, receptor-mediated phospholipase C (PLC) activity triggers phosphatidylinositol-4,5-bisphosphate (PIP 2 ) hydrolysis, leading to information transfer. Coupled with PLC activation is a sequence of reactions spread across multiple compartments which resynthesize PIP 2 , a process essential for supporting sustained PLC signalling. The biochemical strategies coordinating these reactions and, in particular, whether this is a closed cycle with no net addition or loss of metabolites, are poorly understood. Using mathematical models, we find that most closed PIP 2 cycles cannot explain experimentally observed changes in key metabolic intermediates in particular mutants. Thus, we propose that the PIP 2 cycle likely includes at least one metabolic source and one sink whose net activity results in the experimentally observed regulation of this key signalling pathway.
In many eukaryotic signalling cascades, receptor-mediated phospholipase C (PLC) activity triggers phosphatidylinositol-4,5-bisphosphate (PIP 2 ) hydrolysis, leading to information transfer. Coupled with PLC activation is a sequence of reactions spread across multiple compartments which resynthesize PIP 2 , a process essential for supporting sustained PLC signalling. The biochemical strategies coordinating these reactions and, in particular, whether this is a closed cycle with no net addition or loss of metabolites, are poorly understood. Using mathematical models, we find that most closed PIP 2 cycles cannot explain experimentally observed changes in key metabolic intermediates in particular mutants. Thus, we propose that the PIP 2 cycle likely includes at least one metabolic source and one sink whose net activity results in the experimentally observed regulation of this key signalling pathway.
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In addition to water-soluble small molecules, eukaryotic cells also employ lipid molecules as second messengers. These lipids partition into cellular membranes and, in contrast to structural lipids, are often found at very low levels. Phosphoinositides, phosphorylated derivatives of phosphatidylinositol (PI), are a wellknown example of lipid second messengers. The most abundant of these are phosphatidylinositol 4,5 bisphosphate (PIP 2 ) and phosphatidylinositol-4-phosphate (PI4P). PIP 2 is a key chemical intermediate in cellular signal transduction. Many cell surface receptors (such as metabotropic glutamate receptors or T-cell receptors [1] ) transduce the information of a ligand bound state into downstream signals by the activation of phospholipase C (PLC) enzymes at the plasma membrane (PM); PLC catalyses the hydrolysis of PIP 2 to generate the membrane bound lipid diacylglycerol (DAG) and water-soluble inositol 1,4,5 trisphosphate (IP 3 ) both of which have well-known target proteins through which they transfer information [2] . Following these events, both DAG and IP 3 are subject to multistep metabolic conversion leading to the resynthesis of PIP 2 (Fig. 1A) .
Since PIP 2 levels at the PM are low, cells need to rapidly restore its levels at this location during signal transduction so that PLC signalling is not hampered due to depletion of substrate. In doing this, cells face at least two challenges: (a) coordinating the activities of each enzyme that is part of this multistep metabolic conversion; (b) the lipid intermediates that are part of the metabolism of DAG are nondiffusible, yet the enzymes that participate in these reactions are located in distinct subcellular compartments (reviewed in Ref. [3] ). Prominent examples of this include the generation of DAG at the PM by PLC, whereas cytidine diphosphate diacylglycerol synthase (CDS) and PIS that are part of its metabolic conversion back to PIP 2 are located on the endoplasmic reticulum (ER). Further, the phosphoinositide kinases that phosphorylate PI to generate PIP 2 are located at the PM. Thus, PIP 2 resynthesis requires the co-ordinated transfer of lipid intermediates between these compartments. These considerations become especially important if the total amount of lipid intermediates present in a cell that can undergo PLC-dependent PIP 2 turnover is fixed; that is, there is no injection of additional molecules of any intermediate into the cycle. We refer to this scenario as the 'closed' PIP 2 cycle. The biological relevance of such co-ordinated synthesis has been best articulated by the Li 3+ hypothesis proposed by Berridge [4, 5] : since Li 3+ is an inhibitor of inositol 1 monophosphatase (IMPase), an essential enzyme involved in the recycling of inositol back to PI resynthesis; during Li 3+ treatment of cells, the resynthesis of PI, and consequently PIP 2 , should be inhibited consequently downregulating PLC signalling. Crucially, this Li 3+ hypothesis is underpinned by the assumption that the total amount of metabolic intermediates in the PIP 2 cycle is fixed, although there is no experimental evidence to clearly establish this idea. Thus, an analysis of the nature of the PIP 2 cycle and the co-ordination of turnover of intermediates is of crucial importance.
Signal transduction in Drosophila melanogaster photoreceptors is a typical example of G-protein-coupled PLC signalling [6] . Photon absorption by rhodopsin triggers PLC activation leading to the hydrolysis of PIP 2 . The DAG and IP 3 so produced then undergo metabolic conversion to regenerate PIP 2 (Fig. 1B) . The biochemical steps involved in the photoreceptor PIP 2 cycle are orthologous to those described in a range of eukaryotic model systems including mammalian cells [3] . Drosophila mutants that affect most of the enzymatic steps in this cascade have been described (reviewed in Refs [3, [6] [7] [8] ). Importantly, biochemical analysis using both radiolabelling and mass spectrometry has reported changes in the levels of some of the key metabolic intermediates of the PIP 2 cycle, especially DAG and phosphatidic acid (PA) [9] [10] [11] . Interestingly, it has previously been proposed that in Drosophila photoreceptors, the PIP 2 cycle might not be closed but may involve the activity of a lipase that acts as a sink removing DAG from the cycle [12, 13] although this remains unresolved (reviewed in Refs [6, 10] cycle, with a sink and a source that funnels metabolic intermediates through the PIP 2 cycle, is sufficient to explain the data. These results have fundamental implications for our understanding of PLC signalling, a process that underpins numerous basic cellular processes of biochemical importance.
Materials and methods

Experimental methods
Lipid extraction
Ten heads (dissected from 1-day-old flies) were homogenized in 0.1 mL methanol using an automated homogenizer. Synthetic internal standards [46 pmol of PI (12:0/13:0) and 11.14 nmol of 10:0DG] were added prior to homogenization. The methanolic homogenate was transferred into a screwcapped tube. Further methanol (0.3 mL) was used to wash the homogenizer and was combined in the special tube. 0.8 mL chloroform was added and left to stand for 15 min, and 0.88% KCl (0.4 mL) was added to split the phases. The lower organic phase containing the lipids was dried, was resuspended in 400 lL of chloroform : methanol 1 : 2 and was ready for analysis.
Mass spectrometry
Mass spectrometry analyses were performed on a LTQ Orbitrap XL instrument (Thermo Fisher Scientific, Bremen, Germany) using direct infusion method. Stable ESI-based ionization of glycerophospholipids was achieved using a robotic nanoflow ion source TriVersa NanoMate (Advion BioSciences, Ithaca, NY, USA) using chips with the diameter of spraying nozzles of 4.1 lm. The ion source was controlled by CHIPSOFT 8.3.1 (Advion BioSciences) software. Ionization voltages were +1.2 kV and À1.2 kV in positive and negative modes, respectively; back pressure was set at 0.95 psi in both modes. The temperature of ion transfer capillary was 180°C. Acquisitions were performed at the mass resolution R m/ z400 = 100 000. Dried total lipid extracts were re-dissolved in 400 lL of chloroform : methanol 1 : 2. For the analysis, 60 lL of samples was loaded onto 96-well plate (Eppendorf, Hamburg, Germany) of the TriVersa NanoMate ion source and sealed with aluminium foil. Each sample was analysed for 20 min in positive ion mode where DAG was detected. This was followed by an independent acquisition in negative ion mode for 20 min where PI was detected.
Total lipid phosphate measurement
Total lipid phosphate was quantified from each extract prior to infusion into the mass spectrometer. Potassium dihydrogen orthophosphate solution (0-150 lM) for standard curve and 100 lL of extracted lipid samples were dried at 90°C in high-temperature-resistant phosphate-free glass tube, and then 50 lL of 70% (wt/vol) perchloric acid was added and heated in a dry block for 30 min at 180°C. Then, all the tubes were allowed to reach room temperature. At room temperature 250 lL of water, 50 lL of 2.5% (wt/vol) ammonium molybdate and 50 lL of freshly prepared 10% (wt/vol) ascorbic acid were added and mixed for 1 h for colour development. The colour solutions, 130 lL from each tube (in duplicate), were transferred into a well of the 96-well microtiter plate and absorbance was measured at 630 nm. After subtracting the blank absorbance (0 lM phosphate standard) from all absorbance measurement, the samples were compared with the standard curve and total lipid phosphate was quantified.
Lipid identification and quantification
Lipids were identified by LIPIDXPLORER [14] software by matching m/z of their monoisotopic peaks to the corresponding elemental composition constraints. Molecular Fragmentation Query Language (MFQL) queries compiled for all the aforementioned lipid classes. Mass tolerance was 5 p.p.m., and intensity threshold was set according to the noise level reported by XCALIBUR software (Thermo Fisher Scientific). This operation leads to the report of identified lipid species with corresponding intensities [14, 15] in a single results file in .csv file format for the subsequent quantification of lipids. The concentration of a corresponding lipid species (C A ) is finally determined from the ratio of its intensity (I A ) respective to the intensity of the internal standard (I IS ), for which we know the concentration (C IS ). Commonly, lipidomics approaches employ one internal standard per lipid class.
This concentration of a corresponding lipid species (C A ) is finally normalized with the corresponding total lipid phosphate content coming from the respective samples.
Theoretical methods
Construction of mathematical models of the PIP 2 cycle
We made several variants of a mathematical model of the PIP 2 cycle, based on the well-known reaction cascade shown in Fig. 1B . The models consist of differential equations describing the rate of change in amounts (interchangeably called 'level') of each individual component of the cycle. Importantly, given that the lipid intermediates of the cycle cannot diffuse across the cytosol and are, therefore, restricted to the membrane at which they are produced, we model the lipid intermediates that are found both at the PM and the ER as separate components with separate equations (note that in our models because we track the amount, not concentration, of each lipid in each compartment, the different volumes/areas of different compartments are built-in to the model description). In addition, we include reaction rates for the specific transfer of lipid intermediates from one compartment to the other by lipid transfer reactions. In contrast, the other mathematical model of lipid turnover in the PIP 2 cycle that we have found in literature [16] [17] [18] does not include these features of separate lipid compartments and transfer reactions between them.
In our models, we explore different ways to mathematically represent the reaction rates, as indicated in Fig. 2 . The simplest model assumes that all reactions are irreversible and of first order, and there are no external sources or sinks, as shown in Fig. 3A ; thus, for example, the rate of change of PIP 2 level in the PM is described by the following equation,
where the first term on the right-hand side represents the rate of synthesis of PIP 2 from PI4P, and the second term represents conversion of PIP 2 to DAG, with k pip5k and k plc being the corresponding first-order rate constants (the equations for other components are similarly formed by summing all synthesis and consumption reactions for a given substrate -see Appendix S1: Section S1 for the full set of equations). The next variant of the model also uses only first-order reactions and no external sources or sinks, but adds three 'reverse' reactions, as shown in Fig. 3B . Further variants use the reaction schemes of Fig. 3A ,B, but replace the first-order reactions by Michaelis-Menten reactions. Thus, instead of a single reaction constant describing each synthesis and consumption reaction, these variants have two parameters, the maximum reaction rate and the Michaelis constant, as shown in Fig. 2 . Finally, we constructed models that allowed one external source and one sink which, respectively, add or remove lipid from the cycle, such as those shown in Fig. 4A ,B. These models were examined both with first-order, as well as with Michaelis-Menten reactions. From the equations, for each of these models, we expect a single steady state to which all initial conditions will converge for large times, and we found this to be true in all numerical simulations also (using function 'odeint' from the PYTHON 3 SCIPY package, http:// www.scipy.org/).
Sufficiency criteria for comparing the models with experimental data
We conclude a model of the PIP 2 cycle to be sufficient to explain experimental observations if there exists even one set of reaction rate constant values that satisfy all of the following conditions simultaneously: 1 In the wild-type steady state, the levels of the lipid intermediates (relative to total PI) lie within 15% of the values given in Table 1 . 2 Under a 10-fold underexpression of diacylglycerol kinase (DAGK), corresponding to the rdgA 3 mutant, the steadystate DAG/PI total ratio should change by < 15% compared with the wild-type value of this ratio. 3 Under a 10-fold underexpression of LAZA, corresponding to the laza 22 mutant, the steady-state DAG/PI total ratio should change by less than 15% compared with the wildtype value of this ratio. 4 Under a 10-fold underexpression of DAGK, the steadystate PA total /PI total ratio should change by < 15% compared with the wild-type value of this ratio. 5 Under a 10-fold underexpression of LAZA, the steadystate PA total /PI total ratio should increase by 2.5-fold (AE15%) compared with the wild-type value of this ratio.
Whenever we refer to models being 'compatible/incompatible' or 'consistent/inconsistent' with experimental data, or able to 'recapitulate' experimental observations, or the PIP 2 cycle 'cannot/must' have a certain configuration, we always mean that this in reference to the above criteria.
The 15% and 10-fold underexpression are plausible but arbitrary choices given the absence of quantitative estimates of the experimental error and the actual underexpression levels in the mutants. However, it turns out that these are not critical choices -see the section 'Robustness against variation in parameter values'.
Results
Deviations from experimental data in models of a closed PIP 2 cycle
The simplest scenario is one where the PIP 2 cycle is 'closed', i.e., no external sources or sinks exist that add or remove any of the intermediate lipids components of the cycle, and there are only 'forward', irreversible, first-order reactions. In this scenario, the This configuration is able to explain the constancy of DAG/PI ratio in the rdgA 3 mutant. Here, the location of the source at ERPA is crucial;
other locations are incompatible with the experimental observations (see Appendix S1: Section S6).
equations governing the dynamics of the lipid levels are linear (see Eqns (1)- (9) in Appendix S1: Section S1) and are fully specified by nine parameters. With Michaelis-Menten, instead of first-order kinetics, the dynamical equations have 17 parameters. We find that models of the closed PIP 2 cycle with either of these kinetics are inconsistent with experimental data from two mutants (Appendix S1: Sections S1 and S7). First, in rdgA 3 mutants, it has been observed that the ratio of DAG level to total PI level is no different from that in the wild-type [19] . In contrast, our models of a closed PIP 2 cycle predict a substantial increase in this ratio when DAGK activity is decreased. In the model with first-order reactions, the increase is proportional to the decrease in DAGK activity in the mutant (see Appendix S1: Section S1). Second, in mutants lacking the PA phosphatase LAZA (laza 22 ), the ratio of total PA level to total PI level increases by % 250%, compared with the wild-type control [9] . We repeated experiments to measure [PA] total levels laza 22 and were able to reproduce the elevations in this ratio reported in earlier studies [11] . However, in all our models that include LAZA activity, hypomorphs of LAZA exhibit no significant change in this ratio (see Table 2 and Appendix S1: Section S1). Thus, these simple closed cycle models, for both first-order and Michaelis-Menten kinetics, violate our sufficiency criteria (see Materials and Methods). Note that this result is not dependent on the particular values we choose for the reaction rate constants -every possible choice of reaction rate constant values violates the criteria. This inconsistency between the model prediction and experimental data, for all possible values of reaction rate constants, implies that one or more assumptions in the model are not valid and the PIP 2 cycle cannot be the simple closed cycle depicted in Fig. 3A .
More complex closed cycles also deviate from experimental data
In addition to the eight forward reactions, there are in principle three reverse reactions catalysed by a 5-phosphatase (that converts PIP 2 to PI4P) [20, 21] , a 4-phosphatase (that converts PI4P to PI) [22] and a PA phosphatase that dephosphorylates PA to generate DAG [9] (Fig. 3B) . We found that adding these three reactions to our models of the closed PIP 2 cycle did not alter our results. In particular, these models are also unable to explain the increase in PA/PI ratio experimentally observed in laza 22 (Appendix S1: Section S2). A third configuration we investigated (Fig. 3C ) adds one more known element to cycle: In addition to DAG, the activity of PLC on PIP 2 also produces IP 3 as a second product. IP 3 is converted to myo-inositol in a three-step process following which the enzyme PIS condenses myo-inositol to CDPDAG to form PI on the ER. Thus, in a situation where the PLC catalysed production of DAG is very high, it is possible for PI production from cytidine diphosphate diacylglycerol (CDPDAG) to be substrate limited due to the absence of sufficient myo-inositol, a potential effect that our previous models ignored. However, including these steps too cannot explain the large increase of the PA/ PI ratio observed experimentally in the laza 22 mutant (see Appendix S1: Section S3).
There is also experimental evidence to support the existence of feedback loops within the cycle, where a lipid component may affect the activity of an enzyme that is part of the cycle. For example, the activity of PIP5K has been reported to be enhanced with increasing PA levels [23] . Such feedback can be modelled by making the enzyme activity a function of the levels of this lipid component (Fig. 2) . However, for these feedback models, every parameter set that produces a valid steady state for the cycle without feedback has a corresponding parameter set that produces exactly the same steady state for the cycle with the feedback link (see Appendix S1: Section S4). Therefore, a closed cycle with feedback links will not explain the steady-state [PA] total /[PI] total ratio in laza 22 any better than the cycle without feedback.
Robustness against variation in parameter values
In the previous sections, we have ruled out several closed cycle configurations by showing that there exists not even one set of values for the kinetic parameters which would result in steady-state lipid levels that match specific experimental observations from the wild-type strain and two mutant strains (rdgA 3 and laza 22 ). In fact, this conclusion holds even under substantial variation of these experimental observations. For example, if the wild-type steady-state observations took any other values than shown in [32] lipid ratios behaved as in Table 2 , row 1), we would still be able to rule out these closed cycles by the same sufficiency criterion. This follows from the fact that Eqns (43-44), (82-83) and (102-103) in Appendix S1, which we use to rule out these closed cycles, do not depend on these wild-type steady-state values at all.
Further, our closed cycle models all exhibit the following properties: 1 The DAG/PI total ratio in the rdgA 3 mutant relative to the wild-type is inversely proportional to the DAGK activity in the mutant and is thus, typically, substantially larger than 1. 2 For models where a LAZA mediated reaction is present, the PA total /PI total ratio in the laza 22 mutant is unchanged relative to the wild-type.
Thus, variation in experimental observations will not nullify our conclusions as long as experimentally we can say that either the observed DAG/PI total ratio in rdgA 3 mutant relative to the wild-type is sufficiently close to unity, or the PA total /PI total ratio in the laza 22 mutant is sufficiently larger than in the wild-type.
Finally, our results are also robust to certain changes in our sufficiency criteria. Because the change in the DAG/PI total ratio in the mutant closed cycles is inversely proportional to the amount of underexpression of the corresponding enzyme (DAGK), we would be able to rule out all these closed cycles even if our sufficiency criteria had assumed a reduction in expression of only slightly more than 15% (or, in general, slightly more than the value of the experimental error). It is unlikely that the mutants show such little underexpression, so we claim our result of ruling out the closed cycle is robust to changing these choices of values in our sufficiency criteria.
An open cycle topology can recapitulate PA/PI increase in laza 22 Our results, thus far, suggest that the PIP 2 cycle is not a closed cycle, that is, additional lipid must be entering the cycle from external biochemical reactions not included in the closed cycle models, which we will term 'sources'. In order to achieve a steady-state, there must then also be one or more processes ('sinks') that balance the external sources by removing lipid from the cycle. We explored all possible configurations of the PIP 2 cycle which had one source and one sink somewhere in the cycle and asked which source-sink combination, if any, was sufficient to recapitulate the elevated PA/PI ratio observed in laza 22 . Note that, in order to demonstrate sufficiency, it is enough to find a single set of reaction rate constant values that satisfies the sufficiency criteria described in Materials and methods. We do not attempt to find anything resembling 'best-fit' parameter values because this does not add any strength to such a sufficiency result.
We found that indeed some configurations of such an open cycle were able to recapitulate the increased PA total /PI total ratio in laza 22 , while simultaneously being consistent with the observed wild-type lipid ratios of Table 1 . In these successful configurations, the sink could be in only one of two locations, as shown in Fig. 4 . The first possibility for the sink is the PA phosphatase activity of LAZA acting at the PM and generating a pool of DAG that is no longer able to re-enter the PIP 2 cycle (Fig. 4A) . The second possibility is an enzyme, or DAG-binding protein, that metabolizes DAG into a product that cannot be recovered back into the PIP 2 cycle (Fig. 4B) . With either one of these sinks operational, it is possible to Table 2 . Comparison of experimental observations for various mutants with theoretical predictions from our models. Mismatches between experiments and theoretical predictions are indicated in red. The Open Cycle 2 configuration of Fig. 4B is the only one that is consistent with all experimental observations. All numbers are relative to the value of that ratio in wild-type cells and are, therefore, dimensionless. ≫ 1 indicates that all parameter values that are consistent with the wild-type steady-state condition result in a value for that ratio that is much larger than unity. 1 indicates that all parameter values that are consistent with the wild-type steady-state condition result in that ratio being exactly unity. % indicates that there exists at least one parameter set that is consistent with the wild-type steady-state condition and results in a value of that ratio that is approximately the value mentioned (see Appendix S1: Fig. S7 for the results from a range of parameter values). Values presented in 'Open cycle 2' row are taken from simulations done using parameter set provided in Appendix S1: Fig. S8 . However, the former sink, acting on PA at the PM, is inconsistent with the experimental observation that the DAG/PI total ratio remains constant in rdgA 3 mutants that lack DAGK activity (see Appendix S1: Section S5; this result holds irrespective of the location of the source). With the latter sink, namely that based on an enzyme or binding protein capable of metabolizing DAG, it is possible to recapitulate both an elevated PA/PI ratio in laza 22 and the constancy of the DAG/PI ratio in rdgA 3 (see Appendix S1: Sections S6 and S7). Thus, this open cycle, with either first order or Michaelis-Menten reactions, is in fact consistent with all the wild-type and mutant steady-state experimental observations we have used in this paper. Note that, in this case, the location of the source at ERPA is necessary; configurations with the source at other locations are not consistent with the experimental observations (see Appendix S1: Section S6).
We note again that our purpose here is simply to show that this Open Cycle 2 configuration is sufficient to explain the experimental observations. We make no attempt to find the 'best-fit' parameters, because that is not needed to demonstrate sufficiency. Instead, to claim sufficiency, it is enough to demonstrate a single parameter set (as in Appendix S1: Fig. S8 ) that satisfies the criteria we have chosen, namely assuming the mutants exhibit a 10-fold underexpression of the corresponding enzyme, DAG/PI total ratios should change in both mutants by < 15% compared with the wild-type, while the PA total /PI total ratio should change by < 15% in the rdgA 3 mutant and should increase by 2.5-fold (AE15%) in the laza 22 mutant. However, it may be reassuring to point out that we do in fact find many parameter values which satisfy this sufficiency criterion for the Open Cycle 2 with Michaelis-Menten kinetics (see Appendix S1: Table S1 ). In addition, the Open Cycle 2 with Michaelis-Menten kinetics remains sufficient to explain the data even if the LAZA and DAGK expression levels in the corresponding mutants are taken to be as high as 60% of the wild-type (Appendix S1: Fig. S9 ), as well as if the assumed experimental error in our sufficiency criteria was reduced to 6% (Appendix S1: Fig. S8) .
A closed cycle derived from this open cycle topology can explain the data but is very sensitive to fluctuations in the lipid levels One may ask whether connecting the sink to the source in the Open Cycle 2 will produce a closed cycle that can explain the experimental data. The steady-state equations for these two cases indeed match, so this seems likely. However, there is an important difference between open and closed cycles: in open cycle equations (for wild-type as well as mutants), the total lipid content in steady state is uniquely determined by the reaction parameter values, whereas in closed cycle equations, there is complete freedom to choose the total lipid level. Thus, even though the steady-state equations look identical in the two cases, the closed cycle linking the sink to the source admits many different steady states with different total lipid levels. Which steady state is reached would depend, therefore, upon the initial lipid levels one starts with, and will, therefore, also be sensitive to fluctuations due to intrinsic noise in the level of any of the lipids in the cycle. In contrast, open cycles, including Open Cycle 2, are robust to such fluctuations. Thus, every parameter set shown in Appendix S1: Figs S6-S9 and Table S1 that works with our Open Cycle 2 will also work with the derived closed cycle that connects sink to source, but only if the initial conditions are chosen appropriately and we discount fluctuations. Note also that other such closed cycles that 'short-circuit' part of the standard PIP 2 cycle will not be able to explain experimental data for the same reason that other open cycles did not work.
Discussion
The robustness of any signalling system depends on the availability of adequate substrate to fuel the rate limiting biochemical reactions that form part of this pathway. For the PLC-mediated signalling system that is used in diverse biological contexts in eukaryotes, the adequate availability of its low abundance substrate PIP 2 is a key requirement for sustained signalling. This is particularly important in contexts such as neurons where neurotransmitter receptors (e.g., metabotropic glutamate receptors) trigger high rates of PLC activation. The observation that PIP 2 levels undergo only transient, if any, depletion during cell signalling [24] implies that robust biochemical processes underpin the ability of cells to support its levels at the PM.
What might these processes be? The synthesis of PIP 2 in eukaryotic cells is mediated by the sequential phosphorylation of hydroxyl groups at positions 4 and 5 of the inositol ring of PI. Thus, the availability of adequate amounts of PI is a minimal requirement for the resynthesis of PIP 2 . Measurements by mass assays reveal that the mass of PI is about 20 times the levels of either PI4P or PIP 2 . However, most of this PI is located in the ER, a distinct compartment from which it must be made available at the PM where the kinases that generate PIP 2 are located. The mass of PI at the PM is unknown and has remained difficult to determine experimentally although it is widely accepted that the vast majority of the PI in a eukaryotic cell is at the ER. Thus, it is very likely that the pool of PI available at the PM for PIP 2 resynthesis is relatively limited.
Phosphatidylinositol is synthesized by the condensation of CDPDAG with Inositol by the enzyme phosphatidylinositol synthase (PIS). The availability of substrates for this reaction may arise from one of two sources: (a) they may be generated as downstream metabolites from the primary products of PLC activity, that is, IP 3 and DAG. IP 3 is sequentially dephosphorylated to generate Inositol, and DAG is sequentially converted into PA and then CDPDAG. Thus, in the context of a closed cycle, that is, one with no exogenous source of PI, the control of DAG and PA levels during PLC signalling is vital to support PIP 2 resynthesis. (b) PI may be generated by the use of de novo synthesized CDPDAG and Inositol that is transported into cells from the extracellular medium.
In such an open cycle, the conservation and recycling of metabolic intermediates following PLC activity is likely to be less important to maintain PIP 2 levels through resynthesis.
To date, there have been no biochemical measurements/studies that have conclusively defined the PIP 2 cycle during PLC activation as either an open or a closed cycle. Yet, the closed/open nature of this cycle has important functional implications for biological processes. As mentioned earlier, the Li 3+ hypothesis of Berridge, which proposes that the inhibition of IMPase, a key enzyme in the cycling of IP 3 to inositol during PLC signalling, leads to the depletion of PI and consequently PIP 2 , implicitly assumes that the cycle is closed. Likewise, a recent study proposed that the levels of PA regulated by the activity of DAGK and PA phosphatase might limit the resynthesis of PIP 2 in Drosophila photoreceptors during PLC signalling [9] . An open cycle with external sources necessitates a reevaluation of these hypotheses; an additional source of inositol could decouple the rate of PI synthesis from the activity of IMPase, and an external source for PA could similarly counteract changes in the activity of DAGK and PA phosphatase.
In this study, we have constructed a quantitative mathematical model of the PIP 2 cycle. The model revealed anomalies with respect to the steady-state levels of PA and DAG experimentally reported to arise from the manipulation of DAGK and PA phosphatase activity. These anomalies could not be resolved at any point in the parameter space for most closed cycles we examined. However, the experimentally noted elevation of PA levels arising from the loss of PA phosphatase could be recapitulated by assuming the existence of an additional source of PA as well as a sink. It was necessary to assume a sink at one of two locations (Fig. 4) : (a) A PA phosphatase activity at the PM that generates DAG; this pool of DAG being no longer able to participate in the PIP 2 cycle, (b) a DAG metabolizing activity at the PM that is able to convert DAG into metabolites that can no longer participate in the PIP 2 cycle. While either of these sinks, in conjunction with a source, can be invoked to explain the accumulation of PA in the PA phosphatase mutant, the presence of a PA phosphatase activity that creates an unavailable pool of DAG should have resulted in an experimentally measurable elevation in the levels of DAG; such elevations have not been demonstrated so far. For a similar reason, we may rule out the possibility that the sink involves the movement of DAG from the inner to the outer leaflet of the PM [25] where it becomes unavailable to the cycle. By contrast, the presence of a DAG metabolizing activity at the PM provides a parsimonious explanation for lack of elevation of DAG levels when DAGK activity is reduced. Although candidate DAG lipases that function in Drosophila photoreceptors in the context of PLC signalling have been proposed, the enzyme has not been definitively identified. If such a mutant in DAG lipase were isolated, our model predicts that DAG levels would likely be elevated during PLC signalling. In mammalian models, loss of DGK-e has been reported to result in shorter tonic seizures and is associated with accumulation of arachidonic acid that can be generated from DAG by DAG lipase [26] .
We did find one closed cycle, derived from the above open cycle by connecting the sink to the source, that can in principle explain experimental data. However, we believe the open cycle topology to be the more plausible one for two reasons. Mathematically, this derived closed cycle is sensitive to variations in the total lipid level, which might make it a less reliable way of controlling PIP 2 resynthesis than the open cycle we favour. And, biologically, the closed cycle would require additional reactions to transport products of the hypothesized DAG lipase action from the PM to the ER, followed by resynthesis of PA there, and thus far, we have not encountered any evidence for such processes. Nevertheless, this is a possibility that should be kept in mind. We note that the two cycles make contrasting predictions that could be checked in future experiments, namely that a real-time perturbation of one of the lipid levels should produce a permanent change in a closed cycle, but in an open cycle, such a perturbation will correct itself over time.
In our models, the presence of a sink must be matched by a source; otherwise, the total mass of metabolites in the cycle will reduce rapidly. While we have not explicitly examined the case of multiple sources (or indeed multiple sinks), our model predicts that there must at least be one source that injects PA at the ER. Our model cannot say whether this is due to de novo synthesis of PA or its generation by the activation of phospholipase D (PLD). Numerous experiments have shown that cell surface receptors that activate PLC often also activate PLD (reviewed in Ref. [27, 28] ). The significance of PA generated by PLD as a potential source for the PIP 2 cycle needs to be evaluated. Nonetheless, our results highlight the need to establish the sources and sinks that may provide additional points of control for this key signalling cycle.
